Amylyx Pharmaceuticals, Inc. (AMLX)

34.10 +0.14 (+0.41%) USD  |  NASDAQ  |  Sep 04, 16:00
34.12 +0.02 (+0.07%) After-Hours: 20:00
More

Amylyx Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical EPS LT Growth Estimates Data

View and export this data back to 2023. Start Trial.
Date Value
April 04, 2024 --
March 08, 2024 --
Date Value
March 14, 2023 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
EyePoint, Inc. --
Bristol Myers Squibb Co. Upgrade